AU2001261005A1 - Immune mediators and related methods - Google Patents

Immune mediators and related methods

Info

Publication number: AU2001261005A1
Authority: AU; Australia
Prior art keywords: related methods; immune mediators; mediators; immune; methods
Prior art date: 2000-03-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001261005A

Inventor

Subhashini Arimilli

Darrick Carter

Aijun Wang

Shirley Zhu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Corixa Corp

Original Assignee

Corixa Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-22

Filing date

2001-03-22

Publication date

2001-10-03

2001-03-22 Application filed by Corixa Corp filed Critical Corixa Corp

2001-10-03 Publication of AU2001261005A1 publication Critical patent/AU2001261005A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/605—MHC molecules or ligands thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Zoology (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Mycology (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Cell Biology (AREA)
Toxicology (AREA)
Pharmacology & Pharmacy (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Rheumatology (AREA)
Peptides Or Proteins (AREA)

AU2001261005A 2000-03-22 2001-03-22 Immune mediators and related methods Abandoned AU2001261005A1 (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US19127400P	2000-03-22	2000-03-22
US60/191,274		2000-03-22
US20424900P	2000-05-15	2000-05-15
US60/204,249		2000-05-15
US26400301P	2001-01-23	2001-01-23
US60/264,003		2001-01-23
PCT/US2001/009616 WO2001070245A1 (en)	2000-03-22	2001-03-22	Immune mediators and related methods

Publications (1)

Publication Number	Publication Date
AU2001261005A1 true AU2001261005A1 (en)	2001-10-03

Family

ID=27392878

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001261005A Abandoned AU2001261005A1 (en)	2000-03-22	2001-03-22	Immune mediators and related methods

Country Status (4)

Country	Link
EP (1)	EP1307211A4 (en)
AU (1)	AU2001261005A1 (en)
CA (1)	CA2403432A1 (en)
WO (1)	WO2001070245A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2263626T3 (en)	2000-06-05	2006-12-16	Corixa Corporation	LEADING PEPTIDES TO POWER THE RECOMBINANT PROTEIN SECRETION FROM A HOSPEDING CELL.
EP1749889A1 (en) *	2000-06-05	2007-02-07	Corixa Corporation	Leader peptides for enhancing secretion of recombinant protein from a host cell
PL370082A1 (en) *	2001-11-16	2005-05-16	Pharmexa A/S	Novel immunogenic mimetics of multimer proteins
US8314210B2 (en)	2002-07-12	2012-11-20	Dana-Farber Cancer Institute, Inc.	Compositions and methods for the generation of MHC class II compounds by peptide exchange
WO2005054292A1 (en) *	2003-11-25	2005-06-16	The University Of Iowa Research Foundation	Compositions and methods related to a dimeric mhc class i and ii-like molecule (dsmhc i and dsmhc ii)
US7576183B2 (en) *	2003-12-24	2009-08-18	Los Alamos National Security, Llc	Structure-based receptor MIMICS targeted against bacterial superantigen toxins
WO2008116468A2 (en)	2007-03-26	2008-10-02	Dako Denmark A/S	Mhc peptide complexes and uses thereof in infectious diseases
EP3620465B1 (en)	2007-07-03	2025-02-19	Dako Denmark A/S	Improved methods for generation, labeling and use of mhc multimers
WO2009039854A2 (en)	2007-09-27	2009-04-02	Dako Denmark A/S	Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
DK2254592T3 (en)	2008-02-28	2019-09-09	Dako Denmark As	MHC multimers for Borrelia diagnostics and disease
WO2010009735A2 (en)	2008-07-23	2010-01-28	Dako Denmark A/S	Combinatorial analysis and repair
GB0817244D0 (en)	2008-09-20	2008-10-29	Univ Cardiff	Use of a protein kinase inhibitor to detect immune cells, such as T cells
US11992518B2 (en)	2008-10-02	2024-05-28	Agilent Technologies, Inc.	Molecular vaccines for infectious disease
WO2010037402A1 (en)	2008-10-02	2010-04-08	Dako Denmark A/S	Molecular vaccines for infectious disease
WO2020127222A2 (en)	2018-12-17	2020-06-25	Immudex Aps	Panel comprising borrelia mhc multimers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5194425A (en) *	1988-06-23	1993-03-16	Anergen, Inc.	Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
AU729406B2 (en) *	1996-03-28	2001-02-01	Johns Hopkins University, The	Soluble divalent and multivalent heterodimeric analogs of proteins
US6268411B1 (en) *	1997-09-11	2001-07-31	The Johns Hopkins University	Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses
JP2003524369A (en) *	1997-08-19	2003-08-19	マウントシナイスクールオブメディシンオブニューヨークユニバーシティー	Major histocompatibility complex class II element with epitope / immunoglobulin chimeric molecule
CA2302779C (en) *	1997-09-16	2010-02-02	Oregon Health Sciences University	Recombinant mhc molecules useful for manipulation of antigen-specific t-cells

2001
- 2001-03-22 CA CA002403432A patent/CA2403432A1/en not_active Abandoned
- 2001-03-22 EP EP01934857A patent/EP1307211A4/en not_active Withdrawn
- 2001-03-22 AU AU2001261005A patent/AU2001261005A1/en not_active Abandoned
- 2001-03-22 WO PCT/US2001/009616 patent/WO2001070245A1/en not_active Ceased

Also Published As

Publication number	Publication date
CA2403432A1 (en)	2001-09-27
EP1307211A4 (en)	2005-01-05
WO2001070245A1 (en)	2001-09-27
WO2001070245A9 (en)	2002-12-19
EP1307211A1 (en)	2003-05-07

Publication	Publication Date	Title
AU2001213236A1 (en)	2001-12-24	Mini-cyclone biocollector and concentrator
AU2001275441A1 (en)	2001-12-24	Filter arrangement and methods
AU2001241614A1 (en)	2002-05-06	Fluid-activatable adhesive articles and methods
AU2001287898A1 (en)	2002-04-02	Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AU2001253418A1 (en)	2001-10-30	Compounds and methods
AU2002220473A1 (en)	2002-05-15	Toughened plastics and its preparation method
AU2001261005A1 (en)	2001-10-03	Immune mediators and related methods
AU2002211717A1 (en)	2002-05-06	Stresscopins and their uses
AU2001236716A1 (en)	2001-08-20	Antigenic complexes and methods
AU2001260774A1 (en)	2002-04-29	Bio-support and preparing method of the same
AU2001243394A1 (en)	2001-09-12	Compounds and methods
AU2002243386A1 (en)	2002-06-18	Rf2a and rf2b transcription factors
AU2001292936A1 (en)	2002-04-02	Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001295185A1 (en)	2001-11-07	Multiplexing-interleaving and demultiplexing-deinterleaving
AU1083501A (en)	2001-04-23	Antibiotic-metal complex and methods
AU2001266176A1 (en)	2002-01-14	Methods
AU2001265026A1 (en)	2001-12-11	Oilseed extract products and uses
AU2001210572A1 (en)	2002-05-15	Ornament
AU2001253481A1 (en)	2001-11-07	Methods and compositions for eleciting an immune response
AU2001252062A1 (en)	2001-10-30	Steatosis-modulating factors and uses thereof
AU2002235277A1 (en)	2002-05-06	Compounds and methods
AU2001249996A1 (en)	2001-09-03	Hemodialysis assembly and method
AU2002256556A1 (en)	2002-07-01	Sea-trosy and related methods
AU2001237592A1 (en)	2001-09-17	Enzymes and uses relating thereto
AU2001250536A1 (en)	2001-11-12	Methods